Studies
UH CURCu64PSM0003- Staging
Cancer
Radiology
Prostate Cancer
Adult Subjects
This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate cancer.